Nimotuzumab in Treatment of Infiltrating Squamous Cell Carcinoma of Tongue ()
ABSTRACT
A 50-year male patient presented to
outpatient department with a mass on tongue associated with pain. A plain
computerised tomography scan done on 17/01/13 revealed mild growth on lateral
border of tongue with an enlarged jugulo-digastric lymph node measuring 1.8 × 1
cm. Excision of tongue was done and sent for histopathological examination
which revealed infiltrating squamous cell carcinoma. The patient was treated
with 2 cycles of Induction chemotherapy with cisplatin and paclitaxel
administered in q3w schedule. Induction chemotherapy was followed by concurrent
chemoradiotherapy with 6 cycles of nimotuzumab 200 mg and cisplatin 20 mg given
weekly along with 60 gy/30 fractions of radiation using IMRT. Latest CT scan
done on 20/01/2014 revealed no evidence of disease (NED).
Share and Cite:
Prasad, A. (2015) Nimotuzumab in Treatment of Infiltrating Squamous Cell Carcinoma of Tongue.
Journal of Cancer Therapy,
6, 141-145. doi:
10.4236/jct.2015.62015.
Cited by
No relevant information.